DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications
International Journal of Molecular Sciences · 16.07.2026 · 27 (14) · 6336
DOI: 10.3390/ijms27146336 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.07.2026. Verfasst von Mateusz Kozłowski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, Al. Powstańców W…. Hauptthemen laut MEDLINE: DNA Methylation, Ovarian Neoplasms, Septins, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigenetic dysregulation is increasingly recognized as an important contributor to ovarian carcinogenesis, and may provide novel diagnostic and prognostic biomarkers. This study evaluated DNA methylation and mRNA expression of SEPT9 and AKR1B1 in ovarian cancer and benign ovarian lesions and assessed their clinical significance. Tissue samples were obtained from 27 patients with ovarian cancer and 29 patients with benign ovarian lesions. DNA methylation was analyzed by pyrosequencing and mRNA expression by real-time PCR. Associations with clinicopathological variables, serum CA125 and HE4 concentrations, diagnostic performance, and survival outcomes were evaluated. Receiver operating characteristic (ROC) analysis, multivariable logistic regression, Kaplan–Meier analysis, and Cox regression models were performed. Multiple testing was controlled using the Benjamini–Hochberg false discovery rate procedure. Ovarian cancer tissues demonstrated significantly lower SEPT9 methylation (q = 0.008), higher AKR1B1 methylation (q = 0.0008), and lower AKR1B1 mRNA expression (q = 0.035) compared with benign ovarian lesions. SEPT9 methylation showed the highest diagnostic accuracy (AUC = 0.741). Both SEPT9 methylation (OR = 0.92, p = 0.014) and AKR1B1 methylation (OR = 9.69, p = 0.008) remained independently associated with ovarian cancer after adjustment for age and menopausal status. Low AKR1B1 mRNA expression was associated with shorter progression-free survival (p = 0.0007). These findings indicate that SEPT9 methylation and AKR1B1 dysregulation are associated with ovarian cancer. SEPT9 methylation demonstrated the best discriminative ability among the evaluated biomarkers. Further validation in larger independent cohorts is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
- Department of Functional Anatomy, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
- Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Al. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
- Department of Gynecologic Oncology and Reconstructive Gynecology, Department of Obstetrics and Gynecology with the High-Risk Pregnancy Unit, Independent Public Specialist Healthcare Centre "Zdroje", 70-780 Szczecin, Pol…
- Laboratory of Pharmacodynamics, Pomeranian Medical University in Szczecin, Plac Polskiego Czerwonego Krzyża 1, 71-244 Szczecin, Poland.
- Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
ORCID-Profile: Mateusz Kozłowski, Dominika Borzyszkowska, Michał Lubkowski, Nina Komaniecka, Radosław Birger, Piotr Kolczewski, Agnieszka Brodowska, Mateusz Kurzawski, Agnieszka Kempinska-Podhorodecka
Zitieren
APA
Kozłowski, M., Borzyszkowska, D., Lubkowski, M., Komaniecka, N., Mikulka, A., Birger, R., Kolczewski, P., Brodowska, A., Kurzawski, M., Kempinska-Podhorodecka, A., & Cymbaluk-Płoska, A. (2026). DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications. International Journal of Molecular Sciences, 27(14), 6336. https://doi.org/10.3390/ijms27146336
Vancouver
Kozłowski M, Borzyszkowska D, Lubkowski M, Komaniecka N, Mikulka A, Birger R, et al. DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications. International Journal of Molecular Sciences. 2026;27(14):6336. doi:10.3390/ijms27146336
BibTeX
@article{Kozowski2026,
author = {Kozłowski, Mateusz and Borzyszkowska, Dominika and Lubkowski, Michał and Komaniecka, Nina and Mikulka, Aleksandra and Birger, Radosław and Kolczewski, Piotr and Brodowska, Agnieszka and Kurzawski, Mateusz and Kempinska-Podhorodecka, Agnieszka and Cymbaluk-Płoska, Aneta},
title = {DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6336},
doi = {10.3390/ijms27146336}
}
EUVIMED